Maravai LifeSciences Revenue and Competitors
Estimated Revenue & Valuation
- Maravai LifeSciences's estimated annual revenue is currently $669.1M per year.
- Maravai LifeSciences's estimated revenue per employee is $5,484,836
- Maravai LifeSciences's current valuation is $4B. (January 2022)
Employee Data
- Maravai LifeSciences has 122 Employees.
- Maravai LifeSciences grew their employee count by 22% last year.
Maravai LifeSciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Manager Process Excellence | Reveal Email/Phone |
2 | IT Support Manager | Reveal Email/Phone |
3 | Learning & Talent Development, HR Systems | Reveal Email/Phone |
4 | EVP and Chief Financial Officer (CFO) | Reveal Email/Phone |
5 | Talent Acquisition | Reveal Email/Phone |
6 | Director, Global Supply Chain Purchasing | Reveal Email/Phone |
7 | Senior Manager, Human Resources Operations | Reveal Email/Phone |
8 | Senior Manager, Global Payroll | Reveal Email/Phone |
9 | Senior Manager, Global Quality Systems | Reveal Email/Phone |
10 | Sr. Executive Assistant | Reveal Email/Phone |
Maravai LifeSciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Maravai LifeSciences?
Maravai LifeSciences enables the miracles of science and improves the human condition through its portfolio of market-leading companies and proprietary technologies. Biomedical innovation is dependent on a reliable supply of reagents in the fields of nucleic acid production, biologics safety testing, and protein detection. From inventive startups to many of the world's leading biopharma, vaccine, diagnostics and cell and gene therapy companies, customers turn to Maravai to solve their complex discovery challenges and help them streamline and scale from research through clinical trials. TriLink BioTechnologies is a global leader in RNA synthesis and scale up, including mRNA production, yield-enhancing proprietary CleanCap® mRNA capping technology, and CDMO services ranging from research to GMP grades. Glen Research leads in specialty reagents for DNA and RNA oligonucleotide synthesis for a broad range of applications. Cygnus Technologies developed the market for bioprocess impurity detection, process-related impurity analytics and viral clearance prior to human trials, regulatory approval and commercial release. Vector Laboratories is the pioneer of protein labeling and detection reagents for immunohistochemistry, immunofluorescence, glycobiology and bioconjugation. Maravai holds a number of patents and offers innovative products and services including CleanCap®, CleanAmp®, GMPLink™, Antibody Affinity Extraction™ (AAE™), EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV™, Sterling™, Glen Pak™, Glen Gel-Pak™, Poly-Pak™, VECTASTAIN®, VECTASHIELD® and SoluLINK®. Maravai's portfolio companies are ISO-9001:2015 certified and have earned hundreds of thousands of citations in peer-reviewed scientific publications. Founded in 2014 and headquartered in San Diego, Maravai LifeSciences is online at www.maravai.com.
keywords:N/AN/A
Total Funding
122
Number of Employees
$669.1M
Revenue (est)
22%
Employee Growth %
$4B
Valuation
N/A
Accelerator
Maravai LifeSciences News
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI Get Rating) was the recipient of some unusual options trading on Wednesday.
BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY. Bio-Techne. News...
The stock price of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) increased by over 9% during intraday trading today. This is why.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $32.9M | 122 | -8% | $26M |
#2 | $30.6M | 122 | 1% | N/A |
#3 | $26.8M | 122 | 3% | N/A |
#4 | $35.4M | 122 | 3% | N/A |
#5 | $39.4M | 122 | 3% | N/A |